Immunological response to hepatitis B vaccine in polytransfused thalassemic patients.
Hepatitis B is an important infection in thalassemia patients and prevention by vaccination is needed. Immunological response to hepatitis B vaccine in polytransfused thalassmia patients needs more attention.
Alavian
Seyed-Moayed
SM
Tabatabaei
Seyed-Vahid
SV
D000293:Adolescent; D000328:Adult; D002648:Child; D003430:Cross-Sectional Studies; D005260:Female; D006509:Hepatitis B / Q000097:blood / Q000517:prevention & control* / Q000635:transmission; D006510:Hepatitis B Antibodies / Q000097:blood*; D006514:Hepatitis B Surface Antigens / Q000276:immunology*; D017325:Hepatitis B Vaccines / Q000008:administration & dosage / Q000276:immunology*; D006801:Humans; D007117:Immunization, Secondary; D007492:Iran; D008297:Male; D008875:Middle Aged; D014611:Vaccination; D055815:Young Adult; D017086:beta-Thalassemia / Q000150:complications / Q000276:immunology* / Q000628:therapy
D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines